BML-210
Aliases: N1-(2-aminophenyl)-N8-phenyloctanediamide |
Catalog No: 14048 | Format: 25 mg | ¥3,770 | Add to Cart |
Catalog No: 14049 | Format: 5 mg | ¥1,040 | Add to Cart |
Application: Histone Acetylation (HAT & HDAC) |
Chemical Properties
MW = 339.4
C20H25N3O2
CAS 537034-17-6
MP = 168-170°C
98% (TLC); NMR (Conforms)
Description
A novel non-hydroxamic HDAC inhibitor. (IC50 = 5-10 M) (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.
Contents
Tan powder. May be dissolved in DMSO (25 mg/ml); Ethanol (10 mg/ml, warm).
Storage Conditions
Store desiccated as supplied at 4°C for up to 2 years. Store solutions at -20°C for up to 3 months.
References
1. J Savickiene et al. Eur. J. Pharmacol. 2006, 549:9
2. D Herman et al. Nature Chem. Biol. 2006, 10:551
Chemical structure of BML-210.